marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-14-2024
Cocrystal Pharma Financial Ratios 2011-2024 | COCP
Annual Financial Ratios Cocrystal Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.8 | -0.4 | -0.3 | -9.8 | -0.4 | -1.6 | -196.6 | -3.7 | -7.7 | -1485.3 | -2.2 | -29.2 | - |
P/S |
- | - | - | 47.2 | 2.7 | - | - | - | 4929.3 | 16338.8 | - | 13.5 | - |
EPS |
-1.9 | -4.8 | -0.2 | -0.2 | -1.5 | -1.8 | -0.0 | -3.2 | -2.4 | - | -0.1 | -0.1 | -0.1 |
EV (Enterprise Value) |
-7.97 M | -20.8 M | -52.7 M | 63.7 M | 12.9 M | 79.3 M | 136 M | 294 M | 432 M | 396 M | 54.2 M | 243 M | 9.9 M |
EBITDA per Share |
-1.9 | -4.75 | -1.91 | -0.168 | -0.0643 | -2.24 | -0.338 | -4.49 | -2.56 | -0.514 | -1.31 | -1.06 | - |
EV/EBITDA |
4.1 | -7.0 | -4.9 | -1.2 | -14.8 | -2.6 | -7.0 | -25.5 | -13.3 | -107.9 | - | ||
PEG |
-0.0 | -0.0 | -0.0 | -0.12 | -0.03 | 0.0 | -1.98 | 0.11 | 0.01 | -15.18 | 0.01 | 1.61 | - |
P/B |
0.5 | 0.4 | 0.1 | 1.8 | 0.7 | 1.2 | 1.1 | 2.7 | 2.3 | 22.1 | -7.1 | -65.0 | - |
P/CF |
-0.9 | -0.7 | -0.3 | -9.4 | -10.3 | -9.7 | -17.4 | -18.7 | -36.1 | -24.5 | -9.4 | -126.0 | - |
ROE % |
-68.16 | -98.16 | -18.29 | -18.38 | -187.37 | -73.33 | -0.58 | -73.18 | -29.91 | -1.49 | 325.61 | 222.45 | - |
ROA % |
-57.53 | -95.10 | -17.87 | -17.79 | -168.83 | -71.54 | -0.50 | -59.96 | -22.35 | -0.04 | -303.92 | -110.01 | - |
ROCE % |
-66.29 | -97.99 | -18.27 | -18.13 | -8.78 | -93.91 | -6.88 | -86.14 | -24.80 | -2.32 | 54.78 | 384.48 | - |
Current Ratio |
6.4 | 32.1 | 43.1 | 25.0 | 3.6 | 1.9 | 1.5 | 2.7 | 1.5 | 0.7 | 0.5 | 0.3 | - |
DSO |
- | - | - | 100.8 | 35.8 | - | - | - | 945.3 | 11639.4 | - | 17.7 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | 60.5 | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | 27.0 | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | 78.2 | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | 51.2 | - |
All numbers in USD currency
Quarterly Financial Ratios Cocrystal Pharma
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.53 | -0.39 | - | -0.41 | -0.41 | -0.64 | - | -0.7 | -3 | -0.52 | - | -0.48 | -0.04 | -0.04 | - | -0.05 | -0.07 | -0.05 | - | -0.06 | 0.05 | 0.1 | - | -0.06 | -0.05 | -0.06 | 0.2 | -0.08 | -0.09 | -0.11 | -3.06 | -0.03 | -0.14 | -0.17 | -0.05 | - | - | -0.03 | - | -0.01 | 0.01 | - | - | -0.02 | -0.02 | -0.02 | - | - | -0.01 | -0.06 | - | -0.04 | -0.01 | - |
EBITDA per Share |
- | -0.41 | - | - | - | -0.62 | - | -0.69 | -2.99 | -0.51 | - | -0.47 | -0.04 | -0.04 | - | -46.3 | -0.07 | -0.05 | - | -56.4 | -0.05 | 0.1 | - | -0.08 | -0.08 | -0.08 | -0.08 | - | -0.08 | -0.13 | -3.97 | - | -0.01 | -0.01 | -0.06 | -4.98 | -5.39 | -4.83 | - | -3.25 | -3.92 | -4.55 | - | -14.4 | -15.9 | -16.2 | - | 0.01 | 0.01 | -0.01 | - | -0.03 | -0.01 | - |
ROE % |
-75.38 | -56.67 | -40.55 | -51.97 | -49.82 | -87.27 | -66.60 | -71.46 | -64.90 | -19.96 | -14.63 | -19.72 | -19.94 | -22.09 | -15.53 | -22.46 | -24.29 | -23.53 | -1.26 | -4.05 | 0.08 | 3.96 | -7.12 | -2.47 | -1.54 | -1.68 | -1.78 | -70.68 | -70.66 | -71.67 | -73.18 | -27.08 | -25.55 | -23.96 | -29.91 | -50.06 | -88.09 | -15.40 | 27.20 | 38.58 | 88.28 | 28.82 | 35.02 | 37.77 | 29.15 | 37.45 | 124.55 | 214.82 | 302.33 | 302.90 | 111.28 | 90.27 | 20.53 | 0.48 |
ROA % |
-65.21 | -51.93 | -37.97 | -50.45 | -50.17 | -85.32 | -64.70 | -69.47 | -61.76 | -19.50 | -14.23 | -19.15 | -19.30 | -21.37 | -15.03 | -21.27 | -22.59 | -21.46 | -1.14 | -3.86 | -0.35 | 3.01 | -6.95 | -2.91 | -1.80 | -1.70 | -1.54 | -58.23 | -58.12 | -58.84 | -59.96 | -20.88 | -19.60 | -18.19 | -22.35 | -9.76 | -10.51 | -7.52 | 0.70 | -59.81 | -119.33 | -183.17 | -186.21 | -187.58 | -128.43 | -76.29 | -61.59 | -94.72 | -126.48 | -124.14 | -40.83 | -33.12 | -7.53 | -0.18 |
ROCE % |
-46.00 | -31.94 | -29.46 | -40.84 | -37.49 | -86.77 | -66.36 | -71.22 | -64.69 | -19.91 | -14.59 | -19.71 | -19.97 | -21.99 | -15.35 | -22.24 | -24.01 | -23.39 | -1.83 | -5.44 | -2.16 | 0.56 | -9.88 | -11.40 | -9.55 | -8.13 | -7.64 | -82.95 | -82.73 | -84.40 | -86.14 | -29.70 | -29.81 | -28.15 | -24.80 | -13.18 | -20.30 | -20.47 | -12.83 | -1.46 | 18.70 | 32.33 | 35.09 | 25.63 | 4.80 | -14.24 | -0.27 | 79.76 | 169.25 | 193.19 | 92.92 | 80.04 | 16.60 | -3.72 |
Current Ratio |
5.2 | 6.7 | 6.4 | 16.9 | 22.7 | 11.9 | 32.1 | 26.3 | 17.5 | 42.1 | 43.1 | 52.1 | 32.8 | 30.0 | 31.2 | 31.2 | 31.2 | 31.2 | 10.1 | 10.1 | 10.1 | 10.1 | 41.0 | 41.0 | 41.0 | 41.0 | 7.6 | 7.6 | 7.6 | 7.6 | 5.5 | 5.5 | 5.5 | 5.5 | 4.0 | 4.0 | 4.0 | 4.0 | 3.5 | 3.5 | 3.5 | 3.5 | 4.3 | 4.3 | 4.3 | 4.3 | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 103.8 | 91.6 | 118.8 | - | 119.4 | 99.3 | 5.8 | - | - | - | -1.4 | - | - | - | 479.1 | - | 37.6 | 49.1 | 49.4 | - | 121.7 | 108.2 | 260.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 103.8 | 91.6 | 118.8 | - | 119.4 | 99.3 | 5.8 | - | - | - | -1.4 | - | - | - | 479.1 | - | 37.6 | 49.1 | 49.4 | - | 121.7 | 108.2 | 260.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 103.8 | 91.6 | 118.8 | - | 119.4 | 99.3 | 5.8 | - | - | - | -1.4 | - | - | - | 479.1 | - | 37.6 | 49.1 | 49.4 | - | 121.7 | 108.2 | 260.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency